infectious diseases

News

Sanofi and Translate Bio expand mRNA vaccine agreement

Sanofi’s Pasteur vaccines unit and Translate Bio have expanded a collaboration to develop mRNA-based vaccines across all infectious disease areas.

News

GSK begins COVID-19 vaccine trial with Clover

GlaxoSmithKline has begun a COVID-19 clinical trial with China’s Clover Biopharmaceuticals, combining its booster with the biotech’s early-stage vaccine.

News

AZ reportedly mulls biggest-ever pharma merger with Gilead

Almost exactly six years ago AstraZeneca managed to convince investors to reject a takeover bid from Pfizer – and now the UK pharma is reportedly planning its own mega-merger with Gilead. <

News

Gilead begins UK trials of COVID-19 drug remdesivir

Gilead has begun testing its COVID-19 coronavirus antiviral remdesivir in the UK, announcing plans to trial the drug in patients in England and Scotland.

News

Charities bankroll coronavirus drug hunt as outbreak hits economies

Celltrion to develop coronavirus antibody and fast test

South Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working on an antibody-based antiviral and a self-testing diagnosis kit

News